ASHLEY MCINTYRE: Open Payments
NPI 1437926417 · WENTZVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $347 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| PFIZER INC. | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $61 |
| Lilly USA, LLC | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Exact Sciences Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: Wegovy, JARDIANCE, OTEZLA, MOUNJARO, ZORYVE, SPRAVATO, ELIQUIS, VYNDAMAX.
Industry payments across MO — which companies pay providers there.
